Adult T-cell lymphomas/leukaemias Completed Phase 1 / 2 Trials for Doxorubicin (DB00997)

Also known as: ATLL / Adult T-Cell Leukemia-Lymphoma / Leukemia-Lymphoma, Adult T-Cell / Adult T-cell lymphoma/leukaemia / Adult T-cell leukemia / Adult T-cell lymphoma/leukemia (HTLV-1-associated) with failed remission / Adult T-cell lymphoma/leukaemia NOS / Adult T-cell lymphoma/leukemia / T-cell lymphoblastic leukemia acute / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / T-cell type acute leukemia / T-cell type acute leukaemia / T-cell lymphoblastic leukaemia acute

IndicationStatusPhase
DBCOND0025994 (Adult T-cell lymphomas/leukaemias)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01000285EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia LymphomaTreatment